AOD 9604 is a synthetic peptide derived from a specific fragment of human growth hormone (HGH), designed to target fat metabolism without producing the full systemic effects of HGH. It has been studied primarily for its potential role in promoting lipolysis (the breakdown of stored body fat) and inhibiting lipogenesis (the formation of new fat). Unlike full growth hormone, AOD 9604 was developed to avoid significantly increasing IGF-1 levels, which reduces the likelihood of typical growth-hormone–related side effects.
In research settings, AOD 9604 has been explored as a possible aid for weight management and fat reduction, and some studies have also examined its potential effects on cartilage and joint health.
AOD 9604 is a synthetic peptide derived from a specific fragment of human growth hormone (HGH), designed to target fat metabolism without producing the full systemic effects of HGH. It has been studied primarily for its potential role in promoting lipolysis (the breakdown of stored body fat) and inhibiting lipogenesis (the formation of new fat). Unlike full growth hormone, AOD 9604 was developed to avoid significantly increasing IGF-1 levels, which reduces the likelihood of typical growth-hormone–related side effects.
In research settings, AOD 9604 has been explored as a possible aid for weight management and fat reduction, and some studies have also examined its potential effects on cartilage and joint health.
Image 1 of 1